PET imaging using PSMA-ligands has been shown to outperform conventional imaging, such as MRI, CT, and bone scintigraphy. It is particularly advantageous in the setting of biochemical recurrence with low tumor burden. Unfortunately, the availability of PSMA is limited by 68Ga/68Ge generator yield and to a lesser degree scan time.